Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Begleiter A., Lam H. Y., Grover J., Froese E., Goldenberg G. J. Evidence for active transport of melphalan by two amino acid carriers in L5178Y lymphoblasts in vitro. Cancer Res. 1979 Feb;39(2 Pt 1):353–359. [PubMed] [Google Scholar]
- Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
- Dufour M., Panasci L. C., St Germain J., Boulet L. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells. Cancer Chemother Pharmacol. 1985;15(2):125–131. doi: 10.1007/BF00257522. [DOI] [PubMed] [Google Scholar]
- FOLEY G. E., LAZARUS H., FARBER S., UZMAN B. G., BOONE B. A., MCCARTHY R. E. CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer. 1965 Apr;18:522–529. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Goldenberg G. J., Lam H. Y., Begleiter A. Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. J Biol Chem. 1979 Feb 25;254(4):1057–1064. [PubMed] [Google Scholar]
- Matsuoka Y., Moore G. E., Yagi Y., Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1246–1250. doi: 10.3181/00379727-125-32327. [DOI] [PubMed] [Google Scholar]
- McElwain T. J., Powles R. L. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet. 1983 Oct 8;2(8354):822–824. doi: 10.1016/s0140-6736(83)90739-0. [DOI] [PubMed] [Google Scholar]
- Millar B. C., Bell J. B. Comparison of melphalan toxicity in human lymphocytic cells and Chinese hamster cells in vitro: the relationship between DNA-DNA cross-link formation and clonogenic survival. Carcinogenesis. 1987 Sep;8(9):1225–1229. doi: 10.1093/carcin/8.9.1225. [DOI] [PubMed] [Google Scholar]
- Millar B. C., Bell J. B., Lakhani A., Ayliffe M. J., Selby P. J., McElwain T. J. A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro. Br J Haematol. 1988 Jun;69(2):197–203. doi: 10.1111/j.1365-2141.1988.tb07622.x. [DOI] [PubMed] [Google Scholar]
- Millar B. C., Millar J. L., Jones A., Feary S. W., Robertson D., Bell J. B. Activation of murine 'T' lymphomas in the presence of a human myeloma cell line, RPMI-8226, in vivo. Br J Cancer. 1988 Mar;57(3):290–292. doi: 10.1038/bjc.1988.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selby P., Zulian G., Forgeson G., Nandi A., Milan S., Meldrum M., Viner C., Osborne R., Malpas J. S., McElwain T. J. The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies. Hematol Oncol. 1988 Apr-Jun;6(2):173–179. doi: 10.1002/hon.2900060218. [DOI] [PubMed] [Google Scholar]
- Vistica D. T. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. Biochim Biophys Acta. 1979 Jan 19;550(2):309–317. doi: 10.1016/0005-2736(79)90217-7. [DOI] [PubMed] [Google Scholar]
- Vistica D. T. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells. Blood. 1980 Sep;56(3):427–429. [PubMed] [Google Scholar]
